Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Dr. Brooks is a veteran drug development leader whose experience includes roles at Pfizer, 4D Molecular Therapeutics, and Gilead Life Sciences, ...
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:50ET Fed's Cook speaks; 9:45ET S&P Global US Manufacturing PMI, Composite PMI; 1:00ET Fed's Daly and Kashkari speak TODAY’S HIGHLIGHTS: Migrant encounters at US-Mexico border on pace to reach record highs in SeptemberChina climate envoy says phasing out fossil fuels 'unrealistic' China and
– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating prote...
Stoke Therapeutics, Inc. announced the appointment of Ian Smith to its Board of Directors effective September 19. Ian F. Smith is a director of Stoke Therapeutics. He serves as a Senior Advisor to...
– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases – ...